{"id":"iopronic-acid","rwe":[],"tags":[{"label":"iopronic acid","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"oravue","offLabel":[],"synonyms":["iopronic acid","bilimiro","oravue"],"timeline":[],"approvals":[],"brandName":"Oravue","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"iopronic acid","explanation":"Think of it like a key fitting into a lock. Oravue is the key that binds to a specific lock, or protein, in the body, which helps to turn off or on certain cellular processes that are involved in the disease it's meant to treat. This binding action helps to restore balance to the body's normal functioning.","oneSentence":"Oravue works by binding to and modulating the activity of a specific protein or receptor in the body.","technicalDetail":"Iopronic acid is a small molecule that likely interacts with a specific protein or receptor through non-covalent binding, altering its activity and leading to downstream effects on cellular processes."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3200","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=IOPRONIC ACID","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T13:59:33.815137","biosimilars":[],"competitors":[],"genericName":"iopronic acid","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"4P675153BV","CHEBI":"CHEBI:135869","INN_ID":"3281","UMLSCUI":"C0063818","ChEMBL_ID":"CHEMBL2105012","KEGG_DRUG":"D04585","PUBCHEM_CID":"37822","MESH_SUPPLEMENTAL_RECORD_UI":"C006754"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":21,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Oravue, also known as iopronic acid, is a small molecule drug of unknown target and class. Its commercial status and approved indications are currently unknown. As a small molecule, Oravue is likely to work by interacting with specific biological molecules to produce its therapeutic effect. Further information on its pharmacokinetics, safety, and efficacy is needed to fully understand its clinical utility. Its development and ownership history are also unclear.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}